{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4205",
      "entity_text" : "mirtazapine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In addition, mirtazapine given therapeutically (i.e., 2 h post-Con A treatment) attenuated Con A induced liver injury as reflected by a significant improvement in serum ALT levels (XREF_FIG).",
  "reading_complete" : "2020-08-04T11:28:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:25:15Z",
  "trigger" : "induced",
  "evidence" : [ "mirtazapine given therapeutically (i.e., 2 h post-Con A treatment) attenuated Con A-induced liver injury" ],
  "pmc_id" : "6474187",
  "score" : 0
}